Company: CI
Filing Date: 2025-09-04
Form Type: 424B5
Source: 0001140361-25-033868
Chunk: 37

Company: Cigna Group
Filing Date: 2025-09-04
Form: 424B5
Chunk 37
---
 OF CONTENTS
may nevertheless be subject to Similar Laws which may affect their investment in the Notes. Fiduciaries of any such Plans should consult with their legal advisors in connection with an investment in the Notes. Because of the foregoing, the Notes should not be purchased or held by any person investing “plan assets” of any Plan, unless such purchase and holding will not constitute a non-exempt prohibited transaction under ERISA and Section 4975 of the Code or a violation of any applicable Similar Laws.

#### Representation
**Accordingly, by acceptance of a Note, or any interest therein, each purchaser and subsequent transferee of a Note will be deemed to have represented and warranted that either (i) no portion of the assets used by such purchaser or transferee to purchase or hold the Notes constitutes assets of any Plan or (ii) the purchase, holding and subsequent disposition of the Notes by such purchaser or transferee will not constitute or result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or a violation under any applicable Similar Laws.

Each Plan investor is advised to consult with its own advisors on whether an investment in the Notes may be appropriate for the Covered Plan’s circumstances.

The foregoing discussion is general in nature and is not intended to be all-inclusive. Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing or holding the Notes on behalf of, or with the assets of, any Plan, consult with their counsel regarding the potential applicability of ERISA, Section 4975 of the Code and any Similar Laws to such investment and whether an exemption would be applicable to the purchase and holding of the Notes. Neither this discussion nor anything in this prospectus supplement is or is intended to be investment advice directed at any potential purchaser that is a Plan or at such purchasers generally.

PURCHASERS OF THE NOTES HAVE THE EXCLUSIVE RESPONSIBILITY FOR ENSURING THAT THEIR PURCHASE, HOLDING AND SUBSEQUENT DISPOSITION OF THE NOTES COMPLIES WITH THE FIDUCIARY RESPONSIBILITY AND PROHIBITED TRANSACTION RULES OF TITLE I OF ERISA AND SECTION 4975 OF THE CODE AND PROVISIONS OF ANY SIMILAR LAWS, AS APPLICABLE.**

<div align='center'>S-22</div>

TABLE OF CONTENTS

UNDERWRITING (CONFLICTS OF INTEREST) Bof